XORTX Therapeutics Inc (XRTX) — Capital Reinvestment Ratio

Latest as of December 2020: 0.00x

XORTX Therapeutics Inc (XRTX) has a Capital Reinvestment Ratio of 0.00x as of December 2020, meaning it reinvests 0% of its operating cash flow (CA$1.57 Million) in capital expenditures (CA$2.84K). Check XORTX Therapeutics Inc (XRTX) tangible equity ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.00x

Capex / Operating Cash Flow

Operating Cash Flow

CA$1.57 Million

CAD

Capital Expenditures

CA$2.84K

CAD

Data as of

Dec 2020

Most recent filing

XORTX Therapeutics Inc Capital Reinvestment Ratio (2017–2017)

This chart tracks XORTX Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see XORTX Therapeutics Inc operating cash flow efficiency.

Annual Capital Reinvestment Ratio for XORTX Therapeutics Inc (2017–2017)

Year-by-year Capital Reinvestment Ratio for XORTX Therapeutics Inc from 2017 to 2017. See how much free cash does XORTX Therapeutics Inc generate to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (CAD)	Capital Expenditures	YoY Change
2017	0.01x	CA$91.17K	CA$1.17K	—

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow